Cardio Diagnostics Holdings, Inc. (CDIO)
USD 0.4
(-1.95%)
USD 0.4
(-1.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 17.06 Thousand | 950.00 | 901.00 | - |
| Cost of Revenue | 111.62 Thousand | 16 Thousand | - | - |
| Gross Profit | -94.55 Thousand | -15.05 Thousand | 901.00 | - |
| Operating Expenses | 7.25 Million | 4.54 Million | 621.34 Thousand | 609.16 Thousand |
| Selling, General and Administrative Expenses | 7.09 Million | 4.49 Million | 573.88 Thousand | 596.99 Thousand |
| Research and Development Expenses | 145.18 Thousand | 40.44 Thousand | 31.46 Thousand | 1500.00 |
| Other Expenses | - | - | - | 4000.00 |
| Cost and Expenses | 7.25 Million | 4.54 Million | 621.34 Thousand | 609.16 Thousand |
| Operating Income | -7.24 Million | -4.54 Million | -620.44 Thousand | -609.16 Thousand |
| Interest Expense | 6.73 Million | - | - | - |
| Income Tax Expense | - | 112.53 Thousand | 2.00 | - |
| Earnings before Tax | -8.37 Million | -4.66 Million | -620.44 Thousand | -605.16 Thousand |
| Net Income | -8.37 Million | -4.66 Million | -620.44 Thousand | -605.16 Thousand |
| Earnings Per Share Basic | -0.66 | -1.51 | -0.53 | -0.06 |
| Earnings Per Share Diluted | -0.66 | -1.51 | -0.53 | -0.06 |
| Weighted Average Shares Outstanding | 12.68 Million | 3.08 Million | 1.16 Million | 9.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.68 Million | 3.08 Million | 1.16 Million | 9.51 Million |
| Gross Margin | -5.54 | -15.84 | 1.00 | - |
| EBIT Margin | -89.67 | -4652.54 | -670.86 | - |
| Profit Margin | -490.88 | -4906.30 | -688.62 | - |
| EBITDA | -1.53 Million | -4.64 Million | -604.44 Thousand | -598.49 Thousand |
| Earnings Before Tax Margin | -424.40 | -4787.84 | -688.62 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 7870.00 | 15.92 Thousand | 5310.00 | 17.06 Thousand | 10.03 Thousand | 1725.00 |
| Cost of Revenue | 40.78 Thousand | 8380.00 | 95.86 Thousand | 111.62 Thousand | 6179.00 | 4793.00 |
| Gross Profit | -32.91 Thousand | 7548.00 | -90.55 Thousand | -94.55 Thousand | 3851.00 | -3068.00 |
| Operating Expenses | 1.24 Million | 4.16 Million | 1.45 Million | 7.14 Million | 1.45 Million | 2.55 Million |
| Selling, General and Administrative Expenses | 1.24 Million | 4.15 Million | 1.44 Million | - | 1.41 Million | 2.53 Million |
| Research and Development Expenses | 7280.00 | 10.84 Thousand | 7492.00 | - | 38.7 Thousand | 12.31 Thousand |
| Other Expenses | 4794.00 | 4793.00 | -9587.00 | - | 4802.00 | - |
| Cost and Expenses | 1.29 Million | 4.17 Million | 1.54 Million | 7.25 Million | 1.45 Million | 2.55 Million |
| Operating Income | -1.28 Million | -4.15 Million | -1.54 Million | -7.24 Million | -1.44 Million | -2.55 Million |
| Interest Expense | 5817.00 | 5817.00 | 96.1 Thousand | 6.73 Million | 570.38 Thousand | 1.05 Million |
| Income Tax Expense | 4.00 | - | -3.00 | - | 570.38 Thousand | 1.05 Million |
| Earnings before Tax | -1.28 Million | -4.16 Million | -1.38 Million | -8.37 Million | -1.93 Million | -4.02 Million |
| Net Income | -1.28 Million | -4.16 Million | -1.38 Million | -8.37 Million | -1.93 Million | -4.02 Million |
| Earnings Per Share Basic | -0.06 | -0.20 | -0.07 | - | -0.16 | -0.39 |
| Earnings Per Share Diluted | -0.06 | -0.20 | -0.07 | - | -0.16 | -0.39 |
| Weighted Average Shares Outstanding | 22.6 Million | 21.07 Million | 20.54 Million | 12.68 Million | 11.9 Million | 10.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.6 Million | 21.07 Million | 20.54 Million | 12.68 Million | 11.9 Million | 10.24 Million |
| Gross Margin | -4.18 | 0.47 | -17.05 | -5.54 | 0.38 | -1.78 |
| EBIT Margin | -157.77 | -260.53 | -272.34 | - | -139.95 | -1477.15 |
| Profit Margin | -163.66 | -261.40 | -261.57 | -490.88 | -192.66 | -2332.12 |
| EBITDA | -1.24 Million | -4.14 Million | -1.44 Million | - | -1.4 Million | -2.54 Million |
| Earnings Before Tax Margin | -162.96 | -261.05 | -290.40 | -424.40 | -143.99 | -1480.08 |
0K3W
ITGR
9991
RGT
TTKPRESTIG
BRSGF